Skip to main content
. 2022 Apr 28;13(5):783. doi: 10.3390/genes13050783

Figure 3.

Figure 3

Source distribution of candidate neoantigens: (A). HLA class I binding neoantigens (8–11-mer) (B). HLA class II binding neoantigens (15–30-mer).